Coming events
| Peter Olofsson and Malin Hultqvist from Redoxis will attend the Annual EU funded FP6 program Neuropr...Read More >> |
News
| 20100216 - Redoxis annual report for the period 070315 to 080831 was finalised at the annual...Read More >> |
| 20100216 -LU Bioscience AB (LU Bio) together with Karolinska Development AB and Redoxis have founded a new com...Read More >> |
| 20091108 -Malin Hultqvist and Pia Eriksson will attend the 9th ESNI (European School of Immunology) conference...Read More >> |
| 20091108 -Redoxis will attend the 2009 Park Annual meeting organised by Sahlgrenska Science Park in Göteb...Read More >> |
Contact
Redoxis AB
Biotech Building Plan 7
Arvid Wallgrens Backe 20
SE- 413 46 Göteborg, Sweden
(Show map)
E-mail: info@redoxis.se
| ProNoxis |
|
LU Bioscience AB (LU Bio) together with Karolinska Development AB and Redoxis have founded a new company named ProNoxis AB. With the combination of expertise on drugdevelopment from LUbio and Karolinska Development, Redoxis can now focus the partnership in ProNoxis on strict development of novel small molecule drugs for treatment of RA using the NOX2 target. Redoxis will also continue development of other new treatment mechanisms and target identification for treatment of autoimmune diseases.
See also the |
pressrelease